'I’m not insane, my mother had me tested' : the risk and benefits of being labelled 'at-risk' for psychosis. by Welsh,  P. & Brown,  S.
Durham Research Online
Deposited in DRO:
09 January 2014
Version of attached ﬁle:
Accepted Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Welsh, P. and Brown, S. (2013) I'm not insane, my mother had me tested' : the risk and beneﬁts of being
labelled 'at-risk' for psychosis.', Health, risk and society., 15 (8). pp. 648-662.
Further information on publisher's website:
http://dx.doi.org/10.1080/13698575.2013.848846
Publisher's copyright statement:
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
1 
 
‘I’m not insane, my mother had me tested’: The risk and benefits of being labelled ‘at-
risk’ for psychosis  
 
Patrick Welsh 
a, b
 and Sally Brown 
a
 
 
a 
School for Health, The Wolfson Research Institute, Durham University, Stockton-on-Tees, 
U.K. and 
 b 
Early Intervention in Psychosis Service, Tees, Esk and Wear Valleys NHS 
Foundation Trust, Bishop Auckland, U.K.  
 
Abbreviated Title: Being labelled ‘at-risk’ for psychosis.   
 
Address for correspondence: Patrick Welsh, Email: patrick.welsh@durham.ac.uk 
 
 
  
2 
 
 
Abstract 
In this article we examine the identification of young people deemed to be at an elevated risk 
of developing psychosis (often referred to as an At-Risk Mental State for psychosis). 
Although this is not a new concept within psychiatry, there has been a growing interest in this 
topic because of the proposed inclusion of an official ‘Psychosis Risk Syndrome’ in the 2013 
Diagnostic and Statistical Manual. Although we discuss the risks and benefits associated with 
the categorisation of individuals based on the concept of risk itself, we also draw upon 
observations from one of our own research study. We interviewed six adolescents with an 
identified At-Risk Mental State analysing the data using an Interpretative Phenomenological 
Analysis framework. We identified three key themes: ‘It is better to say it’,’ How others 
would take me’ and ‘Just to have somebody to talk to’. Within these themes participants 
endorsed risk identification as a means of personally justifying and explaining their current 
symptoms, as well as providing a sense of optimism that their condition was not yet fully 
formed. Concerns regarding stigmatisation were identified although rarely experienced. 
These findings indicate that there are indeed personal benefits for screening for psychosis risk 
in young people, despite the ‘undesirability’ of identification reported in other areas of health. 
The benefits observed may reflect genuine differences in adolescent mental health or the 
methodological constraints of this exploratory study. Nevertheless, the results contribute to 
the understanding and on-going debate of screening for illness in potential ‘at-risk’ 
populations.  
 
Keywords: categorisation, risk, psychosis, mental health, young people   
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Introduction 
In this article we examine the identification and treatment of young people deemed to 
be at an elevated risk of developing psychosis (often referred to as an At-Risk Mental State 
for psychosis). The purpose of this article is to consider the various risks and benefits of 
diagnosis and screening in general but more specifically within the context of psychosis risk 
itself. We devote a significant proportion of this article to the examination of one of our own 
research studies in which we interviewed a small number of adolescents with an At-Risk 
Mental State  about their personal experiences of identification and treatment. This study will 
set the scene for a final discussion into the future of psychosis risk categorisation and 
possible implications.        
 
Predicting and categorising psychosis 
Being at-risk of psychosis 
Psychosis is a psychiatric term used to describe a state characterised by disturbances in 
sensory perceptions, content of thinking and ideation. Symptoms of psychosis include the 
presence of clear hallucinations and delusions, thought disorder and catatonia (McGorry et 
al., 1996). These symptoms, often referred to as ‘positive’ symptoms, may co-occur or in 
some instances co-exist with ‘negative’ symptoms such as reduced motivation, social 
withdrawal, poverty of speech and affective blunting.  
Although research findings vary according to the population studied and length of 
follow-up, often the outcomes of those affected by the condition are poor, both in terms of 
illness course and day-to-day functioning (Leff et al., 1992, Mason et al., 1995). The illness 
process may have significant detrimental effects on personal, social and occupational 
functioning (Agerbo et al., 2004, Marwaha and Johnson, 2004) whilst outcomes may be 
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especially poor for those who develop psychosis as adolescents (Mason et al., 1995, Schmidt 
et al., 1995, Fleischhaker et al., 2005). Patients with the condition also experience a higher 
than expected mortality rate with suicide accounting for a large proportion of deaths (Harris 
and Barraclough, 1998). Psychotic illness generates both direct (health care related) costs as 
well as indirect costs to society through unemployment and financial benefit provision. 
Indeed a significant proportion of health care expenditure (in terms of in-patient care and 
medication) is consumed annually in relation to psychosis care (McCrone et al., 2008; NICE, 
2008). 
Given these individual and societal costs it is no surprise that for almost a century 
there has been interest in the possibility of intervening early, before the onset of a full 
psychotic illness (Sullivan, 1927/1994). Within the last twenty years, criteria to identify 
individuals deemed to be at imminent risk of developing the condition have been established 
with the ultimate aim of preventing a future psychotic episode altogether. By focussing on the 
developmental period of peak onset and combining a variety of different risk factors such as 
genetic predisposition and clinical features observed during the earliest stages of the illness, 
individuals can now be labelled as having an ‘At-Risk Mental State’ for psychosis with the 
subsequently developed criteria referred to as Ultra High Risk (Yung et al., 2003).    
This At-Risk Mental State indicates a high probability but not a certainty of 
developing a psychotic disorder in the near future (McGorry and Singh, 1995) and is 
predominately characterised by attenuated or sub-threshold positive symptoms associated 
with help seeking behaviour and chronically low or deteriorating psycho-social functioning. 
As hoped, the adoption of this Ultra High Risk based strategy initially led to a significant 
increase in the predictive ability to identify individuals destined to become psychotic. In 
Australia for example where the criteria was first conceptualised, transition rates (to 
psychosis) of around 40-50 per cent within a 1-2 year follow up period where subsequently 
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observed  (Yung et al., 2003, Mason et al., 2004). Since then the At-Risk Mental State label 
has been widely applied in research and clinical settings worldwide.   
In recent years, interest in this ability to predict psychosis, through risk identification, 
has grown to the extent that a ‘psychosis risk syndrome’ was proposed (although later 
withdrawn) for possible inclusion in the latest version of the American Psychiatric 
Associations Diagnostic and Statistical Manual of Mental Disorders (DSM-V; Carpenter and 
Tandon, 2013).   
 
Risks and benefits of diagnosis 
The benefits of being diagnosed with a recognised illness have long been recognised, 
beginning with Parsons’ (1951) identification of the sick role, giving permission to be 
excused from normal commitments in return for compliance with the expectation of a desire 
to get well. The sick individual is treated for their illness rather than blamed for their 
deviance (Freidson, 1972) and diagnosis acts as a means to explain and allow for what makes 
the individual ‘different (deviant) from the norm’ (Jutel, 2009, p. 279). However, being 
labelled as having a disease, particularly a chronic illness, may result in ‘biographical 
disruption’ (Bury, 1982), ‘loss of self’ (Charmaz, 1983) and require ‘narrative reconstruction’ 
(Williams, 1984) which has an impact on the labelled individual’s identity affecting how they 
make sense of themselves and their life. As Jutel and Nettleton suggest: 
 
A diagnosis can vindicate and blame, can legitimise or stigmatise, can facilitate 
access to resources just as it can restrict opportunities. A diagnosis can be 
welcomed or eschewed.  (Jutel and Nettleton, 2011, p. 797)  
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One of the particular issues with diagnoses in mental health relates to the problems of 
classifying diseases; until something is classified as a disease, it cannot be diagnosed, but as 
the example of homosexuality shows, being listed as a disease in the Diagnostic and 
Statistical Manual and later removed, diagnostic categories are not certain and fixed. The 
Diagnostic Statistical Manual of Mental Disorders was first produced by the American 
Psychiatric Association in 1952 (DSM-I), and is now in its fifth iteration (DSM-V). It is 
heavily relied upon by clinicians, researchers, insurance companies and policy makers in 
order to classify psychiatric symptoms into diagnostic categories, thus potentially aiding 
understanding and facilitating treatment of a particular disorder. It has been controversial, 
particularly concerning the inclusion and exclusion of some conditions, for example, 
homosexuality as mentioned above; earlier versions have been criticised for ‘psychiatric 
expansionism’ (Holmes and Warelow 1999; p172) by labelling almost all behavioural traits 
as potentially indicative of psychiatric disorder. Mental health conditions in particular are 
difficult to diagnose accurately especially in terms of whether they will lead to violent 
behaviour (Langan, 2010), and distinctions (between schizophrenia and personality disorder) 
are not clear cut, with diagnosis sometimes being made on pragmatic grounds (Warner and 
Gabe, 2004). Manning (2000) argues that the classification of personality disorders is a 
particularly difficult, if not disputed area in terms of diagnostic categories and the Diagnostic 
and Statistical Manual.  
Classifications and diagnosis are particularly important in mental health because of 
the link with risk assessment. Psychiatrists rely on ‘endlessly shifting mental disorder 
classifications’ (Heyman et al., 2012, p.109) as they attempt to identify and assess risk in 
order that it can be managed. As McGuire points out, risk assessment is legitimate in that it 
attempts to identify people who might harm others (as well as people who may harm 
themselves) and: 
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The overarching aim is the avoidance or minimisation of harm. However, unless 
risk assessment is completely veridical, axiomatically there exists the possibility 
of error such that other harms can be done. (McGuire, 2004, p. 329)  
 
Those other harms include stigmatisation and negative aspects of being labelled, 
which for adolescents may be particularly challenging. Some diagnoses in children and 
young people, such as Asperger’s Syndrome for example, may influence a child’s life to their 
advantage or disadvantage but have clear long term risks should diagnosis not take place 
(Portway and Johnson, 2005). As we will now examine, these same disadvantages and 
advantages may accrue to adolescents diagnosed as ‘at risk’ of psychosis.   
 
The risks of being labelled ‘at-risk’ 
Research in areas such as genetic testing indicates that people are not always keen to know 
their own risk status especially if, as in the case of Huntington’s disease, they can do nothing 
to change the trajectory of the disease (Wexler, 1995). When individuals do learn their risk 
status, it can often have a powerful impact with patients and family members experiencing 
acute anxiety, depression and interpersonal strain (Heinssen et al., 2001). Many individuals 
then go on to report examples of discrimination and hostility from life insurers, employers, 
family members and health care professionals (Yang et al., 2010). In the field of testing for 
breast cancer risk in America women often opt to pay for testing privately to avoid raising the 
suspicions of current and future insurers (Corcoran et al., 2005).  
With Huntington’s disease the probability of developing the condition after positive 
identification is virtually 100 per cent (Corcoran et al., 2005). Using the Ultra High Risk 
criteria to identify an At-Risk Mental State for psychosis does not carry the same predictive 
certainty. As we noted above initial research indicates a 40-50 per cent transition to psychosis 
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within a 1-2 year follow up period (Yung et al., 2003, Mason et al., 2004); these figures have 
gradually declined as more and more individuals are recruited to research studies. More 
recent figures indicate a transition rate of around 16 per cent after two years (Yung et al., 
2008). This poor predictive ability is certainly a problem when we consider that various 
interventions have so far been used in order to alter the proposed trajectory of those deemed 
‘at-risk’. For example antipsychotics and antidepressants have been adopted based upon the 
notion that brain maturation is disturbed in those with emerging psychosis (Pantelis et al., 
2003). It has been proposed that these agents could potentially protect or limit the potential 
decline in brain maturation (Berger et al., 2007) and significantly alter and improve the long 
term prognosis of an individual’s condition by potentially limiting its progression and 
preserving a person’s ability to respond to future treatments (Perkins et al., 2005). 
However, little is known about the effect that antipsychotic medication may have on 
the developing adolescent brain (Bentall and Morrison, 2002) and without infallible 
prediction many of those treated this way will have been exposed to risk of taking  
antipsychotic medication unnecessarily. Studies have suggested that young people in 
particular are prone to neuroleptic side effects (Fraguas et al., 2008) whilst long term use 
carries the possible risk of brain shrinkage (Ziermans et al., 2011). Indeed significant side 
effects have been noted in several At-Risk Mental State trials thus far, such as weight gain 
(McGlashan et al., 2006, Woods et al., 2007), and increased prolactin levels resulting in high 
study drop out (Ruhrmann et al., 2007). Although it is relatively easy to highlight the side-
effects and potential negatives of medication use, limited attention has been directed towards 
the use of psychological therapies that have also been utilised as a form of psychosis 
prevention. Indeed side effects are likely to exist but they appear much harder to quantify 
given the lack of formal testing. For example the offering of Cognitive Behavioural Therapy 
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to individuals who may never develop psychosis and currently have no diagnosable mental 
health problem, could be pathologising.  
From the current criteria and research conducted so far there is also no consensus as 
to how long identified individuals should be treated. It is also unclear whether an individual 
remains ‘at-risk’ for the rest of their lives even if the factors believed to be predisposing them 
to any future risk have remitted/been removed. Some research groups have withdrawn the 
label of risk when individuals fail to reach the Ultra High Risk criteria upon reassessment 
twelve months after initial identification (Simon and Umbricht, 2010).  
There is a strong possibility that individuals thus labelled will experience alienation, 
since obtaining a diagnosis of psychosis is often perceived as detrimental with many 
individuals feeling as if others perceive them to be different or unacceptable (Knight et al., 
2003). Opponents of the psychosis risk syndrome suggest that any use of a ‘psychosis’ label 
would interfere with a patient’s ability to communicate with others, making them withdraw or 
limit social contact to those accepting of their condition. Adolescents may be particularly 
vulnerable to labels which stigmatise, because they are at a stage of life when social 
acceptance and autonomy are key to their identity formation (Moses, 2009). For adolescents, 
anticipated peer rejection is probably a major concern given that many people endorse the 
view that children who obtain mental health treatment are likely to be outsiders at school. 
Adolescents’ perceptions of peers with psychosis are also extremely negative with the 
majority endorsing attitudes that suggest those with the condition are more violent, suicidal 
and academically poor. Adolescence is a time when young people are rapidly negotiating 
developmental goals and obtaining their own self-concept. Consequently a mental illness 
label may interfere with these processes. There is also a risk that the illness role becomes 
central to the young person’s identity and threatens a future sense of normality. This is 
something that has been observed for other conditions with about 20 per cent of adolescents 
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identifying their own mental illness label as a core aspect of themselves (Moses, 2009). 
Labelling seems to have a greater impact (in terms of self-stigma and secrecy) among 
adolescents who are younger with less well formed identities.  It has also been shown that 
labelling-induced stigma can be devastating in terms of reduced self-esteem, greater feelings 
of depression and demoralisation, poor treatment adherence and reduced social contact 
making a relapse more likely (Yang et al, 2010).  
Parents of those with 22q11 deletion syndrome (a genetic syndrome resulting from the 
deletion of a section on chromosome 22) report the strain of living with uncertainty (these 
individuals have a 25-30 per cent risk of developing psychosis sometime during their lives) 
and the struggle to differentiate between normal changes in behaviour and those that are 
cause for alarm (‘over vigilance’; Hercher and Bruenner, 2008). Although individuals with 
22q11 are often at risk for other medical conditions, families indicate that the risk of 
psychosis causes them the greatest anxiety. Qualitative research exploring the experiences of 
siblings of individuals with psychosis indicate that brothers or sisters also act as a valuable 
resource in engaging in recovery, normalisation activities and providing opportunities for 
socialising (Sin et al., 2008). However, in this context of risk identification it is unclear if 
siblings would come to perceive themselves as being at risk based on their brother or sisters 
supposed status.    
 
Potential benefits of identifying those ‘at-risk’ 
As we have previously stated the ultimate aim of identifying risk in this instance has been to 
prevent the onset of a full first episode of psychosis. If these aims are indeed successful, this 
would have significant implications for identified individuals in terms of quality of life and 
future access to education and employment. Financially the benefits of potentially preventing 
psychosis, in even a handful of individuals (by reducing future long term medication costs, 
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inpatient bed days, welfare benefits) are likely to exceed the cost of identifying and treating 
those at supposed risk. However, even if professionals cannot prevent transition, prompt and 
effective treatment as soon as the individual becomes psychotic may preserve functioning and 
improve short to long term outcomes (Yang et al., 2010). If identification is not made 
(especially in adolescents where long term outcomes associated with psychosis are worse; 
Schmidt et al., 1995, Fleischhaker et al., 2005) this could represent a significant missed 
opportunity.   
Advocates of any formalised psychosis risk syndrome have argued that clearly 
defining the condition will direct future research and resources to an important clinical 
population as well reduce the potential for misdiagnosis. Psychiatry will be more aligned with 
other fields of medicine that identify risk factors for the purposes of instituting preventative 
interventions (Nelson and Yung, 2011).  For example, graduations of blood pressure and 
cholesterol have long been identified as conferring quantified risk for cardiovascular disease. 
Here preventive efforts have been applied to promote and/or preserve good health (Corcoran 
et al., 2010).  
Although it has been postulated that those who never make the transition to psychosis 
may experience a lasting sense of fragility, others have suggested that individuals with an At-
Risk Mental State are by no means asymptomatic (Ruhrmann et al., 2010). Engagement and 
support from  services (due to identification) may help to shed light on the various presenting 
symptoms (distressing psychotic like symptoms, depression, anxiety and other common co-
morbidities that are often present in this patient group; McGlashan, 2005). The label may 
result in prompt and effective treatment reducing symptoms thereby decreasing stigma (Yang 
et al., 2010) as symptoms and behaviour usually shape community rejection rather than labels 
themselves.  
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Some researchers have suggested that the At-Risk Mental State label, rather than 
increasing apprehension as is the case with a diagnosis of psychotic illness, may open the 
door for new optimism that outweighs any anxiety as symptomatic patients know that some 
form of treatment is forthcoming (Corcoran et al., 2005). By not providing a label for a 
person’s symptoms and an adequate explanation, individuals may tend to stay in a state of 
denial (thus letting their condition worsen) or they may never experience the sense of relief a 
diagnosis/label can provide. Feelings of confusion and worthlessness are often replaced with 
relief when service users affected by psychosis are provided with accurate meaningful 
information (Kilkku et al., 2003; Koivisto et al., 2004). Coping, engagement, medication 
adherence and long term outcome also appear to be much improved when people are more 
informed about their diagnosis of psychosis (Dudley et al., 2009). These observations are 
confirmed in adolescents diagnosed with depression (Wisdom and Green, 2004) since many 
appear to experience relief when hearing about their diagnosis as it validates their distress and 
reassures them that they were not the only person to experience these symptoms. It was also 
observed in this study that the label helped young people make sense of their distress and 
seek information to reduce their symptoms. Not only may the identified individual benefit 
from identification but family members may do so as well. Parents of individuals with 
psychosis suggest the label of a mental illness can offer a way to deal with the negative 
feelings they had experienced towards their child and a diagnosis gave them hope of potential 
treatment and recovery (Muhlbauer, 2002). Accurate psychiatric labels may also help young 
people in that they are more likely to be perceived as ‘sick’ (and therefore deserving of help 
and sympathy) rather than ‘weak’, although accurate labelling of psychosis must address 
widely–held ideas about dangerousness and unpredictability (Wright et al., 2011). At-risk 
labelling is potentially harmful but as we can see in many cases it may also be helpful and 
important from the perspective of the individual, supporting family and society as a whole.  
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What are the views of those individuals subsequently categorised? 
Despite the numerous arguments for and against categorisation, many of the views expressed 
have not considered the potential concerns of those individual who have be so categorised. 
As Yang et al noted that:  
 
No studies to date have systematically examined how any potential stigma 
induced by the psychosis risk syndrome impacts identified patients (Yang et al., 
2010, p. 43) 
  
Speculative observations from one or two specialist at-risk clinics have suggested that 
young people and their families experience a range of feelings and emotions when presented 
with the label. Some experience relief and tend to feel ‘better’, possibly because they are not 
currently psychotic (Yung et al., 2007). Others demonstrate concern, scepticism and denial in 
response to the news (McGlashan et al., 2007) which does not seem surprising given many 
young people’s tendency to ignore psychotic symptoms in order to cope with their difficulties 
(Boydell et al., 2006).  
In order to address these concerns our research group undertook the first and at the 
moment only qualitative study with the aim of investigation the understanding and 
experiences of adolescents thus categorised (Welsh and Tiffin, 2012; Welsh, 2013). The 
decision to focus upon an adolescent age group was based on the notion that wrongful 
identification and potentially harmful and unnecessary treatment would have the greatest 
impact in those so young.  
 
Methods 
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Our aim was to conduct an exploratory study using a small pragmatic survey in order to 
capture participant experience. We chose a semi-structured face-to-face interview design to 
obtain deep personal discussions, allowing for researcher flexibility in questioning style and 
content. We decided to undertake  individual interviews conducted by a mental health 
professional rather than focus groups or use an independent researcher for ethical and 
practical reasons. These included the possible discussion of highly sensitive and personal 
information with young, vulnerable and symptomatic participants with difficulties associated 
with social anxiety, suspiciousness and trust.  
We recruited six adolescents (aged between 13-18 years of age), accessing mental 
health services in the North-East of England for the study on which this article is based. 
These individuals were selected opportunistically from a cohort of adolescents already 
participating in another local study, conducted by the primary author (Patrick Welsh), aimed 
at characterising how adolescents with an At-Risk Mental State initially present to mental 
health services in terms of symptomatology and psychosocial functioning (Welsh and Tiffin, 
2013). We only invited  individuals to participate if they had been identified with an At-Risk 
Mental State for a period of at least six months and had not developed a full blown psychotic 
illness within that time. Conducted interviews were recorded and fully transcribed with the 
written informed consent of the participants. The study was given ethical approval by the 
Durham University School of Medicine and Health Ethics Committee and the National 
Health Service Research Ethics Service. The demographic details of each participant and 
assigned pseudonyms (in order to protect identity) can be seen in Table 1 and indicate a 
relatively heterogeneous group in terms of age, gender and mental health status at the time of 
interview.  
 
[Insert Table 1 here]    
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As the study was concerned with obtaining rich detailed accounts of peoples 
experiences of being labelled (as well as experiences of treatment and support), we analysed 
all data  using an Interpretative Phenomenological Analysis (IPA) framework (Smith et al., 
2009). Interpretative Phenomenological Analysis is a relatively new technique that focuses in 
detail upon how individuals experience and perceive major life events and is informed by 
three key areas of philosophy: phenomenology (the study of experience and how we come to 
understand our lived world), hermeneutics (the theory of interpretation) and idiography (the 
study of the particular/individual). The technique aims to avoid making prior assumptions 
and hypotheses and sees the research participant as the expert who can offer understanding by 
relaying their own stories, feelings and experiences. After the initial descriptive analysis we 
undertook a more interrogative and interpretative examination of the transcript and initial 
notes. We aimed to move to a more conceptual level, moving away from the more explicit 
claims of the participant and incorporating elements of personal reflection, experience and 
questioning by the analyst. We sought to identify issues which were perceived to be 
important in understanding the participant’s world and the matters they were discussing 
(conceptual comments). Once we had analysed each transcript we looked for patterns and 
connections across cases. This involved identifying themes which are the most frequent or 
potent. For example the frequency of comments relating to the ‘Reactions of others’; family, 
peers or society as a whole and actual or predicted, were represented in all participant 
accounts (except Donna’s) making this a significant component for the analysts in 
understanding the participants experience.  
 
Findings 
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In our analysis of the interview transcript we identified three major themes and in this article 
we will focus on the two themes that relate to potential risk/benefits of labelling discussing 
each in turn.   
 
‘It is better to say it’: information about risk status  
In their interviews all participants said that they wanted to be informed about their 
condition/risk status. In reflecting upon his own personal contact with mental health services, 
Frederick (an 18 year old) stated  that withholding information could just make things worse 
over the longer term and he found it refreshing for professionals to be upfront with him about 
his condition:  
 
You were really straight forward and that’s the way I prefer it. I don’t like it when 
people tiptoe around things ‘cos then, when you actually realise it [that you are ill] it 
just hits you hard and causes too much stress. It is better if you are going to be told 
something like you have schizophrenia or we believe that you are suffering from a 
form of depression, it is better to say it.  
 
For another participant, Ethan (aged 15 who we asked specifically about his reaction to 
being identified as being ‘at-risk’), the At-Risk Mental State label confirmed that other 
people have similar difficulties. This appeared to help him normalise his pre-psychotic 
experiences and self-perceptions.  
 
It felt more of a relief to sort of know you weren’t alone…. you feel a lot more sort of 
comfortable knowing that you are not a freak. 
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This sentiment was also echoed by Andy (a 16 year old) when asked to describe his 
own experiences of being told he was at-risk of developing psychosis. He reasoned that if the 
condition has been recognised and had a name then mental health services should be able to 
help him. Andy also said that he felt reassured by professional validation of his beliefs that 
something was wrong.  
 
I knew there was obviously something wrong and the fact that somebody 
acknowledged that and I kind of had something to go away with that I knew somebody 
else had already noticed, then I could work with that… If I hadn’t been given anything 
then I might have been more worried about the future and stuff because I didn’t know 
what was going on. With, the At-Risk Mental State kind of label it was helpful ‘cos 
then I could read up and I knew how it was going to be dealt with.  
 
‘How others would take me’: The response of peers 
Participants in our study were concerned about whether or not to communicate the label to 
other people and the effect of this information on ‘how others would take me’ (Claire aged 
16) if they knew. Both Bethany (aged 13) and Claire especially felt anxious about what 
people might say about them in the future if they discovered they had been given a 
psychiatric label. Claire noted that ‘they [other people] are going to look at me and think 
what’s wrong with her’. For this reason remaining quiet was seen as the best option and 
utilised frequently when dealing with other peers, teachers and even family members with 
Bethany stating that: ‘I don’t go mentioning it to anybody.’.  
Although participants were understandably reluctant and cautious about telling their 
friends about their condition, chance incidents could bring their condition out into the open. 
For Bethany the experience of having her thought diary read by one of her friends was 
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actually positive as her worst fear of being perceived as ‘crazy’ or a ‘psycho’ was not 
confirmed. In fact Bethany said that the incident showed that despite her condition people 
were still willing to accept her as a friend.  
 
I kept a diary of my thoughts and feelings and things, like I was told to do and I took it 
to school in case I had an experience and as I was writing, one of like my closest 
friends, who she didn’t actually know about my problems, she snatched it off me ‘cos 
she thought it was just like a general book I was writing in and she had a look and she 
felt so sorry for me. So that made me a bit more happier that she didn’t exactly think I 
was completely crazy.   
 
Although having his diagnosis made public did not appear to have been as significant 
for Frederick (aged 18) in terms of his self-esteem, it did serve to confirm that his friends 
were both supportive and generally concerned about his well-being. In his interview he 
described how and why he could no longer keep his condition private and the positive 
reactions of his friends:  
 
Most of my friends saw me taking my medication and they asked, they realised that it 
wasn’t multivitamins or anything like that ‘cos they saw the actual pill packet and 
asked what I was doing and I thought well there is no point in hiding it and I told them. 
And they just asked how I got to the state I was in and if there was anything they could 
do to help.  
 
Despite positive interactions with close friends, some individuals did experience some 
negative stigmatisation from their peers. Although Bethany (aged 13) had been particularly 
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worried about experiencing this type of reaction, the experience when it occurred did not 
appear to be particularly upsetting. Her friend’s opinions and their unconditional acceptance 
appeared to be the only view that really mattered upon reflection on these incidents.  
 
Yeah a few people have ‘cos I have the odd few people who take the mick out of me 
but then I have my close friends that don’t like, don’t, haven’t really changed much, 
when I have told them.  
 
Discussion 
Much of the literature on risk and screening points to the undesirability of being labelled as ill 
or at risk of disease as a result of screening. This is particularly the case where people have 
been symptom free, for example never having experienced ill-health related to their bones but 
having been diagnosed as at risk of osteoporosis (Salter et al., 2011); although it may also be 
the case where individuals or their families have noticed changes, for example relating to the 
development of dementia (Milne, 2010). In addition, risk models are increasingly being used 
to identify high risk populations, particularly for certain cancers, who may then be offered 
screening (Holmberg and Parascandola, 2010). This then creates new categories of disease-
free but ‘at risk’ individuals in need of intervention; furthermore, ‘being given a risk status 
during a symptomless pre-disease state may change an individual’s self-perception as healthy 
into that of a patient’ (Salter et al., 2011 p810); and this may change their behaviour (such as 
not wanting to go outside any more) or their feelings about themselves in negative ways.  
 The undesirability of a diagnosis resulting from screening seems to be strongly related 
to whether or not the person now labelled as a ‘patient’ had experienced any symptoms prior 
to being given the ‘at risk’ label. With physical diseases, the labelling may have taken place 
at a symptomless, or ‘pre-symptomatic’ stage, with mental illnesses the individual may 
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already be aware of themselves as being different (Portway and Johnson, 2005). As Portway 
and Johnson point out, labelling people as anything other than “normal” is unpopular, but 
there are positive as well as negative consequences of applying a diagnostic label. In 
particular, with some diagnoses, such as Asperger’s syndrome or an At-Risk Mental State, 
there are risks associated with not having an early enough diagnosis, such as not having 
access to treatment, educational interventions or social support that makes the problem 
manageable. For our participants, being screened and given a diagnosis provided benefits in 
the form of relief: being able to ‘put a name’ (Jutel 2011) to a problem they already felt they 
had; and also in the form of managing: now they had an accepted label, it could be managed. 
 Some screening, for example genetic and pre-natal screening, gives rise to 
‘manufactured uncertainty’ (Giddens, 1994) and surveillance anxiety (Burton-Jeangros et al., 
2013), particularly in terms of waiting for an outcome that may or may not happen (the 
emergence of a hereditary condition, the birth of a chromosomally abnormal baby), and are 
examples of a risk approach which is designed to improve control over bad outcomes but at 
the same time increases uncertainty for the individuals concerned. In contrast, for our 
participants the screening process and subsequent diagnosis had increased their feelings of 
certainty, even though they were also potentially waiting for an outcome that may not 
happen, in the sense that although they were labelled as having an At-Risk Mental State, they 
may never develop psychosis themselves. 
 Being given a diagnosis or an ‘at risk’ label allocates the individual to a new social 
group (Milne, 2010), and where mental health is concerned this is often one that is viewed 
negatively. One of the reasons that older people resist a diagnosis of dementia is due to its 
association with several social problems (Milne, 2010) and the young people in our study 
were certainly aware of the potential drawbacks to their diagnosis becoming known, in terms 
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of how their friends and people around them would react. However, despite their fears, their 
friends had been understanding and supportive once their diagnosis had become known. 
 While many challenge risk surveillance and the expansion of screening, for the 
individuals in our study screening gave them more control and relieved, rather than 
exacerbated, the anxieties they had been feeling about their mental state. 
 
Future directions  
Since this study (at the time of writing) is novel in the examination of experiences relating to 
the assignment of an At-Risk Mental State label, it is difficult to assess the transferability of 
our findings given the lack of previous literature. However, the recruitment strategy adopted 
by the study may have been biased to those with positive experiences of services and 
labelling, given the opportunistic nature of selecting individuals already engaged within a 
research project and the decision not to interview those who had subsequently developed 
psychosis. In reflecting upon the usefulness of the Interpretative Phenomenological Analysis 
approach for the purposes of this study, the aim of obtaining rich and detailed accounts from 
individuals experiencing an At-Risk Mental State were only partly fulfilled. Although there 
was sufficient data to generate themes and inferences from the interviews conducted, many 
participants found it particularly difficult to fully articulate their experiences. At times, these 
difficulties led to relatively short and superficial interviews. More detailed and ‘open’ 
accounts in relation to personal experience, may have been forthcoming had we employed a 
service user researcher (rather than a psychiatric professional) to conduct subsequent 
interviews. Studies that have adopted this method have predominately obtained more critical 
and potentially ‘honest’ accounts of service provision (Simpson and House, 2002). All these 
factors make further exploration of what it feels/means to be labelled as having an At-Risk 
Mental State for psychosis even more compelling.    
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Indeed, the omission of the proposed psychosis risk syndrome from the Diagnostic 
and Statistical Manual of Mental Disorders, version five (DSM-V) may not signal the end of 
this on-going debate. For example it is highly likely that individuals presenting to mental 
health services will continue to receive an At-Risk Mental State label for the foreseeable 
future, given its (in some areas widespread) clinical use. A possibility has therefore been 
muted in relation to a change in terminology and a move away from categorisation via risk 
status. The proposal for an ‘Attenuated Psychotic Syndrome (APS)’ is one suggestion which 
may be more palatable for many different stakeholders. In the first instance it solves the 
problem of declining transition rates and identification of ‘false’ positive cases (individuals 
who will never go on to develop psychosis) as all patients would already have distressing 
sub-threshold psychotic symptoms. Kaymaz and van Os, (2010) have questioned the 
accuracy of this notion of risk before, arguing that identified individuals should not be 
considered ‘at-risk’ but ‘cases’ in their own right because of their already elevated levels of 
disability and distress. In addition this group would still be at higher risk for developing 
psychosis but not explicitly labelled as thus. This could be viewed in the same way as 
diagnosing and treating angina not only because it is an illness in itself but also to prevent 
myocardial infarction (Arango, 2011). From our own research, we have seen that young 
people desire a label that validates/describes their psychotic like experiences. This term 
Attenuated Psychotic Syndrome offers this without the potential anxiety and connotations of 
being labelled ‘at-risk’, although it could be construed as reducing the diagnostic threshold 
for psychiatric illness.  
The inclusion of a psychosis risk syndrome in the forthcoming Diagnostic and 
Statistical Manual may have indeed been too premature (Nelson and Yung, 2011) and the 
subsequent decision by the American Psychiatric Association working group to withdraw its 
inclusion can easily be justified. However its inclusion within the appendix for ‘Criteria sets 
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and axes provided for further study’ has been confirmed and seems worthwhile at this time 
(Carpenter and Tandon, 2013). We therefore hope that this decision will increase the scope 
for research that directly involves and listens to the views and concerns of those identified as 
this is an area of research that is clearly lacking and must be addressed immediately. It is 
unclear at this time whether this decision will reduce or increase attention and enthusiasm for 
the categorisation and recognition of future ‘risk’ in other areas of psychiatry such as bi-polar 
affective disorder (Manic depression; Bechdolf et al., 2012).  
   
Conclusion 
In this paper we have outlined the current psychiatric practice of identifying individuals 
perceived to be at an elevated risk of developing a psychosis illness and the associated risks 
and benefits of this process. The issue of risk labelling has a broader relevance beyond 
psychiatry, though, as the widely accepted, though false, perception of mentally ill people is 
that they pose a high level of risk to others; indeed the risk they pose to society is often 
perceived to be much higher than it actually is, and the risks they pose to themselves much 
lower than in reality. Debates about risk in relation to mental health involve issues about 
individual rights and how they can be balanced with wider social needs for safety and the 
minimising of potential harms.  However, as Heyman (2004) points out, it is impossible to 
predict with any accuracy who might harm or offend, leaving policy-makers and practitioners 
in a position of uncertainty.  This position is usually dealt with by using the language of risk, 
and attempts to quantify levels of risk. Although the reported study is informative regarding 
the benefits of risk screening and psychiatric labelling, the findings are incongruent in 
comparison to those reported in other areas of health, possibly reflecting the studies 
exploratory nature. Finally it is unclear whether future risk identification in psychiatry and 
research focussing on the personal experiences of screening will be affected by the American 
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Psychiatric Association decision to omit the At-Risk Mental State as a full diagnostic term in 
the most recent adaptation of the Diagnostic and Statistical Manual.   
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Table 1. Key demographic details  
 
Participant  Age, years Gender Current symptom status 
at the time of interview 
Andy 16 Male Full symptom remission  
Bethany 13 Female ARMS 
Claire 16 Female ARMS 
Donna 16 Female ARMS 
Ethan  15 Male Full symptom remission 
Frederick 18 Male ARMS 
 
 
 
